Literature DB >> 3460570

The long-term follow-up of women with gestational diabetes.

P T Grant, J N Oats, N A Beischer.   

Abstract

Four hundred and forty-seven women who had gestational diabetes have been retested at intervals from 1 to 12 years following diagnosis; 49 (11%) were found to be diabetic and 35 (7.8%) had impaired glucose tolerance using the WHO criteria. An abnormal glucose tolerance test in the puerperium and obesity at the time of retesting had significant associations with abnormal glucose tolerance at follow-up. However, the best predictive factor of the likelihood of the development of significant hyperglycaemia was the recurrence of gestational diabetes in a subsequent pregnancy, since 28% of these women were diabetic and a further 4% had impaired glucose tolerance at the time of follow-up. These findings indicate that the criteria used for the diagnosis of gestational diabetes at the Mercy Maternity Hospital, Melbourne (1-hour greater than or equal to 9 mmol/l together with a 2-hour greater than or equal to 7 mmol/l) are appropriate for an Australian population.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3460570     DOI: 10.1111/j.1479-828x.1986.tb01521.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  9 in total

Review 1.  Windows of Opportunity for Lifestyle Interventions to Prevent Gestational Diabetes Mellitus.

Authors:  Suzanne Phelan
Journal:  Am J Perinatol       Date:  2016-08-03       Impact factor: 1.862

2.  Can the birth of a large infant predict risk for atherosclerotic vascular disease in the mother?

Authors:  J Spjuth; G Larsson; P Nilsson-Ehle; B Schersten; B Astedt
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

3.  The risk factors and incidence of type 2 diabetes mellitus and metabolic syndrome in women with previous gestational diabetes.

Authors:  Majid Valizadeh; Nooshin Alavi; Saeideh Mazloomzadeh; Zahra Piri; Hamidreza Amirmoghadami
Journal:  Int J Endocrinol Metab       Date:  2015-04-20

4.  Postpartum follow up of gestational diabetes in a Tertiary Care Center.

Authors:  C A Cabizuca; P S Rocha; J V Marques; T F L R Costa; A S N Santos; A L Schröder; C A G Mello; H D Sousa; E S G Silva; F O Braga; R C Abi-Abib; M B Gomes
Journal:  Diabetol Metab Syndr       Date:  2018-01-03       Impact factor: 3.320

Review 5.  Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus.

Authors:  Joon Ho Moon; Soo Heon Kwak; Hak C Jang
Journal:  Korean J Intern Med       Date:  2017-01-01       Impact factor: 2.884

6.  Protocol for a randomized controlled trial of pre-pregnancy lifestyle intervention to reduce recurrence of gestational diabetes: Gestational Diabetes Prevention/Prevención de la Diabetes Gestacional.

Authors:  Suzanne Phelan; Elissa Jelalian; Donald Coustan; Aaron B Caughey; Kristin Castorino; Todd Hagobian; Karen Muñoz-Christian; Andrew Schaffner; Laurence Shields; Casey Heaney; Angelica McHugh; Rena R Wing
Journal:  Trials       Date:  2021-04-07       Impact factor: 2.279

7.  Development of type 2 diabetes in women with comorbid gestational diabetes and common mental disorders in the Born in Bradford cohort.

Authors:  Claire A Wilson; Gillian Santorelli; Rebecca M Reynolds; Emily Simonoff; Louise M Howard; Khalida Ismail
Journal:  BMJ Open       Date:  2022-03-14       Impact factor: 2.692

8.  Early diabetes screening in women with previous gestational diabetes: a new insight.

Authors:  Aline Nabuco; Samara Pimentel; Carolina A Cabizuca; Melanie Rodacki; Denise Finamore; Marcus M Oliveira; Lenita Zajdenverg
Journal:  Diabetol Metab Syndr       Date:  2016-08-27       Impact factor: 3.320

9.  Oral Glucose Tolerance Testing Allows Better Prediction of Diabetes in Women with a History of Gestational Diabetes Mellitus.

Authors:  Tae Jung Oh; Yeong Gi Kim; Sunyoung Kang; Joon Ho Moon; Soo Heon Kwak; Sung Hee Choi; Soo Lim; Kyong Soo Park; Hak C Jang; Joon Seok Hong; Nam H Cho
Journal:  Diabetes Metab J       Date:  2018-12-07       Impact factor: 5.376

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.